Brind.

RBC provided a target price and rating for Verastem Oncology.

1 report, 1 independent Updated Aug 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Verastem Oncology Royal Bank of Canada

Keep exploring

The entities involved

Verastem Oncology
Pharmaceutical company in Masachussets, United States

Nothing else this week.
Royal Bank of Canada
financial institution in Canada
- Royal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Mon 16:02
- PrairieSky Royalty Ltd. operates in the Western Canadian Sedimentary Basin and is currently receiving research ratings from Royal Bank of Canada (RBC).Mon 09:02

Related events

Coverage

Newest first; wire copies grouped

Aug 5themarketsdaily.com